- Home
- LNTH vs AES Comparison
LNTH vs AES Comparison
Compare LNTH & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- AES
- Stock Information
- Founded
- LNTH 1956
- AES 1981
- Country
- LNTH United States
- AES United States
- Employees
- LNTH N/A
- AES N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AES Electric Utilities: Central
- Sector
- LNTH Health Care
- AES Utilities
- Exchange
- LNTH Nasdaq
- AES Nasdaq
- Market Cap
- LNTH 3.8B
- AES 9.6B
- IPO Year
- LNTH 2015
- AES 1991
- Fundamental
- Price
- LNTH $51.19
- AES $14.09
- Analyst Decision
- LNTH Buy
- AES Hold
- Analyst Count
- LNTH 6
- AES 10
- Target Price
- LNTH $74.50
- AES $15.00
- AVG Volume (30 Days)
- LNTH 1.4M
- AES 9.1M
- Earning Date
- LNTH 11-06-2025
- AES 11-04-2025
- Dividend Yield
- LNTH N/A
- AES 4.98%
- EPS Growth
- LNTH N/A
- AES N/A
- EPS
- LNTH 2.39
- AES 1.46
- Revenue
- LNTH $1,525,933,000.00
- AES $12,094,000,000.00
- Revenue This Year
- LNTH N/A
- AES $1.04
- Revenue Next Year
- LNTH $1.98
- AES $4.54
- P/E Ratio
- LNTH $21.34
- AES $9.32
- Revenue Growth
- LNTH 1.95
- AES N/A
- 52 Week Low
- LNTH $47.25
- AES $9.46
- 52 Week High
- LNTH $111.29
- AES $15.51
- Technical
- Relative Strength Index (RSI)
- LNTH 36.35
- AES 50.08
- Support Level
- LNTH $54.76
- AES $13.21
- Resistance Level
- LNTH $61.92
- AES $14.60
- Average True Range (ATR)
- LNTH 2.36
- AES 0.45
- MACD
- LNTH -0.44
- AES -0.07
- Stochastic Oscillator
- LNTH 4.15
- AES 58.09
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.